Ind-Swift Laboratories Ltd Q1 FY24 consolidated PAT at Rs. 17.24 crores

Ind-Swift Laboratories Limited has reported Consolidated financial results for the period ended June 30, 2023.

Financial Results (Q1 FY2024) - QoQ Comparison

The company has reported total income of Rs. 315.9446 crores during the period ended June 30, 2023 as compared to Rs. 314.4526 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs. 17.2424 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs. -25.1235 crores for the period ended March 31, 2023.

The company has reported EPS of Rs. 2.92 for the period ended June 30, 2023 as compared to Rs. -4.25 for the period ended March 31, 2023.

Financials	Q1 FY2024	Q4 FY2023	% Change
Total Income	₹ 315.9446 crs	₹314.4526 crs	0.47%
Net Profit	₹17.2424 crs	₹-25.1235 crs	168.63%
EPS	₹2.92	₹-4.25	168.71%

Financial Results (Q1 FY2024) - YoY Comparison

The company has reported total income of Rs. 315.9446 crores during the period ended June 30, 2023 as compared to Rs.287.5582 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs.17.2424 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs.19.8793 crores for the period ended June 30, 2022.

The company has reported EPS of Rs.2.92 for the period ended June 30, 2023 as compared to Rs.3.36 for the period ended June 30, 2022.

Financials	Q1 FY2024	Q1 FY2023	% Change
Total Income	₹ 315.9446 crs	₹287.5582 crs	9.87%
Net Profit	₹17.2424 crs	₹19.8793 crs	-13.26%
EPS	₹2.92	₹3.36	-13.10%

Shares of Ind-Swift Laboratories Limited was last trading in BSE at Rs. 98.03 as compared to the previous close of Rs. 98.88. The total number of shares traded during the day was 26920 in over 488 trades.

The stock hit an intraday high of Rs. 101.65 and intraday low of 97.05. The net turnover during the day was Rs. 2680604.00.

Source : Equity Bulls

Keywords

IndSwiftLaboratories Q1FY24 ResultUpdate